The Molecular Neurobiology of Depression - 15/08/11
Doi : 10.1016/j.psc.2006.12.005
Richard C. Shelton, MD a, b, ⁎ 
a Department of Psychiatry, Vanderbilt University Medical Center, 1500 21st Avenue, South, Suite 2200, Nashville, TN 37212, USA
b Department of Pharmacology, Vanderbilt University Medical Center, 1500 21st Avenue, South, Suite 2200, Nashville, TN 37212, USA
Department of Pharmacology, Vanderbilt University Medical Center, 1500 21st Avenue, South, Suite 2200, Nashville, TN 37212.Abstract |
The molecular neurobiology of depression begins with the concept that depressive disorders represent a family of related but distinct conditions. Different points of vulnerability in the brain may predispose a person to depressive disorders. Unraveling these complex causes may lead to novel treatments that can be used in a targeted fashion.
Le texte complet de cet article est disponible en PDF.Plan
| Supported in part by NIMH grants MH073630, MH01741, and MH52339. |
© 2007
Elsevier Inc. Tous droits réservés.
Vol 30 - N° 1
P. 1-11 - mars 2007 Retour au numéro
Article précédent
- Preface
- Dan V. Iosifescu, Andrew A. Nierenberg
- A Critical Overview of the Pharmacologic Management of Treatment-Resistant Depression
- Andrew A. Nierenberg, Judith Katz, Maurizio Fava
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?